Sarepta Therapeutics, Inc.

Overview

Sarepta Therapeutics, Inc. is a medical research and drug development company focused on developing precision genetic medicines to treat rare neuromuscular diseases. With a primary emphasis on Duchenne muscular dystrophy, the company utilizes innovative RNA-based platforms to address unmet medical needs.

Therapeutic areas

API / Drug Master Files

Sarepta Therapeutics, Inc. holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SRP-2001 DRUG SUBSTANCEInactive2023-02-28

FDA compliance signals